0000950123-20-005093.txt : 20200515 0000950123-20-005093.hdr.sgml : 20200515 20200515081512 ACCESSION NUMBER: 0000950123-20-005093 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 EFFECTIVENESS DATE: 20200515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bain Capital Life Sciences Fund, L.P. CENTRAL INDEX KEY: 0001687968 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-18478 FILM NUMBER: 20880704 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-516-2000 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-NT 1 primary_doc.xml 13F-NT LIVE 0001687968 XXXXXXXX 03-31-2020 03-31-2020 false Bain Capital Life Sciences Fund, L.P.

200 Clarendon Street Boston MA 02116

13F NOTICE 028-18478 028-18477 Bain Capital Life Sciences Investors, LLC 028-18476 Bain Capital Life Sciences Partners, LP Y The report on Form 13F for the period ended March 31, 2020 for Bain Capital Life Sciences Fund, L.P. (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of the Fund. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 05-15-2020